Scholarly Index
Steven M. Kornblau
The University of Texas MD Anderson Cancer Center; 31,565 total citations; 791 total publications; best world rank #92
The University of Texas MD Anderson Cancer Center
31,565Total citations
791Total publications
96H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 92 | US 55 | 99.68 |
| Acute Lymphoblastic Leukemia research | Lifetime | 275 | US 149 | 98.90 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 263 | US 137 | 98.71 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 606 | US 280 | 98.46 |
| Protein Degradation and Inhibitors | Lifetime | 263 | US 153 | 97.90 |
| Histone Deacetylase Inhibitors Research | Lifetime | 331 | US 180 | 96.85 |
| Multiple Myeloma Research and Treatments | Lifetime | 748 | US 334 | 96.45 |
| Cell death mechanisms and regulation | Lifetime | 676 | US 279 | 95.69 |
| Advanced Biosensing Techniques and Applications | Lifetime | 414 | US 137 | 94.84 |
| Retinoids in leukemia and cellular processes | Lifetime | 881 | US 423 | 93.89 |
| Acute Myeloid Leukemia Research | 2021-2025 | 192 | US 112 | 98.22 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 205 | US 116 | 96.54 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 584 | US 255 | 94.29 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 378 | US 179 | 93.14 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 564 | US 165 | 81.81 |